Who
Eva Anette Engelhardt
EVP, President, CDG
Company insider
Files Form 4 as: EVP, President, CDG, Bio-Rad Laboratories.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $271K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jul 2024
- Last trade
- 6 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,152 at $0.00 | filing |
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,152 at $0.00 | filing |
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $187K485 at $386.11 | filing |
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,152 at $0.00 | filing |
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,152 at $0.00 | filing |
| 6 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $187K485 at $386.11 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,027 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $142K369 at $386.11 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,027 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,027 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,027 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $142K369 at $386.11 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,313 at $0.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,313 at $0.00 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —246 at $0.00 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $28K89 at $314.46 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —246 at $0.00 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —246 at $0.00 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —246 at $0.00 | filing |
| 25 Jul 2026filed 28 Jul 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $28K89 at $314.46 | filing |
News
Head to Head Comparison: Bio-Rad Laboratories (NYSE:BIO) versus Medpace (NASDAQ:MEDP)BIO · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Eva Anette Engelhardt; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.